Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem Lems

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Annals of the Rheumatic Diseases|November 4, 2018
Response to: 'Knee osteoarthritis and bisphosphonates: Could BCP crystals be the missing link?' by Murphy <i>et al</i>Willem Lems
Therapeutics and Clinical Risk Management|August 30, 2008
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritisPiet Geusens, Willem Lems
Nature Reviews. Rheumatology|July 29, 2009
Fracture prevention in menPiet Geusens, Philip Sambrook, Willem Lems
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 22, 2026
Is Zoledronic acid cost-saving in daily practice?Willem Lems, Joop van den Bergh, Caroline Wyers
RMD Open|March 17, 2021
Antirheumatic drugs for cardiovascular disease prevention: the case for colchicineWillem Lems, Maarten Boers, Ronald F van Vollenhoven, et al.
Expert Opinion on Biological Therapy|November 28, 2022
Romosozumab for the treatment of postmenopausal women at high risk of fracturePiet Geusens, Natasha Appelman-Dijkstra, Willem Lems, et al.
Expert Opinion on Drug Discovery|November 24, 2025
The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracturePiet Geusens, Wim Van Hul, Joop van den Bergh, et al.
RMD Open|November 12, 2015
OsteoRheumatology: a new discipline?Marta Favero, Andrea Giusti, Piet Geusens, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 8, 2023
Argentine Guidelines for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Postmenopausal Women and Men Aged 50 Years and OlderJorge Luis Alberto Morales Torres, Luis Fernando Vidal Neira, Osvaldo Daniel Messina, et al.
Current Medical Research and Opinion|October 7, 2010
Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension studyJosé R Zanchetta, Cesar E Bogado, Carlo Cisari, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Annals of the Rheumatic Diseases|November 4, 2018
Response to: 'Knee osteoarthritis and bisphosphonates: Could BCP crystals be the missing link?' by Murphy <i>et al</i>Willem Lems
Therapeutics and Clinical Risk Management|August 30, 2008
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritisPiet Geusens, Willem Lems
Nature Reviews. Rheumatology|July 29, 2009
Fracture prevention in menPiet Geusens, Philip Sambrook, Willem Lems
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 22, 2026
Is Zoledronic acid cost-saving in daily practice?Willem Lems, Joop van den Bergh, Caroline Wyers
RMD Open|March 17, 2021
Antirheumatic drugs for cardiovascular disease prevention: the case for colchicineWillem Lems, Maarten Boers, Ronald F van Vollenhoven, et al.
Expert Opinion on Biological Therapy|November 28, 2022
Romosozumab for the treatment of postmenopausal women at high risk of fracturePiet Geusens, Natasha Appelman-Dijkstra, Willem Lems, et al.
Expert Opinion on Drug Discovery|November 24, 2025
The preclinical discovery and development of romosozumab for the treatment of people with severe osteoporosis who are at high risk of fracturePiet Geusens, Wim Van Hul, Joop van den Bergh, et al.
RMD Open|November 12, 2015
OsteoRheumatology: a new discipline?Marta Favero, Andrea Giusti, Piet Geusens, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 8, 2023
Argentine Guidelines for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Postmenopausal Women and Men Aged 50 Years and OlderJorge Luis Alberto Morales Torres, Luis Fernando Vidal Neira, Osvaldo Daniel Messina, et al.
Current Medical Research and Opinion|October 7, 2010
Treatment of postmenopausal women with osteoporosis with PTH(1-84) for 36 months: treatment extension studyJosé R Zanchetta, Cesar E Bogado, Carlo Cisari, et al.
Pageof 4